The Significance of Vasoactive Intestinal Peptide in Immunomodulation

  title={The Significance of Vasoactive Intestinal Peptide in Immunomodulation},
  author={M. Delgado and D. Pozo and D. Ganea},
  journal={Pharmacological Reviews},
  pages={249 - 290}
  • M. Delgado, D. Pozo, D. Ganea
  • Published 2004
  • Biology, Medicine
  • Pharmacological Reviews
  • First identified by Said and Mutt some 30 years ago, the vasoactive intestinal peptide (VIP) was originally isolated as a vasodilator peptide. Subsequently, its biochemistry was elucidated, and within the 1st decade, their signature features as a neuropeptide became consolidated. It did not take long for these insights to permeate the field of immunology, out of which surprising new attributes for VIP were found in the last years. VIP is rapidly transforming into something more than a mere… CONTINUE READING
    260 Citations

    Figures, Tables, and Topics from this paper.

    Vasoactive intestinal peptide, periodontal disease, and the innate immune response: an interview with Dr. John J. Taylor
    • H. Rosenberg
    • Medicine, Biology
    • Journal of leukocyte biology
    • 2007
    Role of vasoactive intestinal peptide in osteoarthritis
    • 20
    • Highly Influenced


    Immunology of VIP: a review and therapeutical perspectives.
    • 155
    Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases
    • 148
    • PDF
    Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs.
    • D. Ganea
    • Biology, Medicine
    • Advances in neuroimmunology
    • 1996
    • 124
    The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation.
    • 126
    • Highly Influential
    The effects of vasoactive intestinal peptide on human natural killer cell function.
    • 114
    Expression of vasoactive intestinal peptide in lymphocytes: a possible endogenous role in the regulation of the immune system.
    • 60
    Vasoactive intestinal peptide inhibits IL-8 production in human monocytes.
    • M. Delgado, D. Ganea
    • Biology, Medicine
    • Biochemical and biophysical research communications
    • 2003
    • 33
    • PDF
    Cutting Edge: Is Vasoactive Intestinal Peptide a Type 2 Cytokine?
    • 101
    • PDF
    Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity.
    • 63
    Complex array of cytokines released by vasoactive intestinal peptide
    • 54